MSD founded a special antibody business unit just for ‘Keytruda’

MSG has a high hope towards its antibody ‘Keytruda’.

Merck has recently spoken that it will launch Oncology Business Units at its branches all over the world, including the Korean branch.

For the reason, Joseph Eid Merck, Global Pharmaceutical CEO, visited Korea to discuss about the formation of the unit and completed appointing personnel, including its chief, in the department.

Its movement...